Merck forms review panel on Vioxx
478691
Merck&#39;s board of directors yesterday formed a special committee to review the drug maker&#39;s handling of the controversial painkiller Vioxx.
196378
A top Republican lawmaker on  Wednesday called on Merck & Co. Inc. to answer questions about  its withdrawn drug Vioxx at the first congressional hearing on  Nov. 18 to address the arthritis medicine's safety problems.
280625
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol medicine Vytorin after a study showed it was no better than a generic drug in preventing the build-up of fatty plaque.
254339
Drug maker Merck & Co. Inc. on  Tuesday said its board appointed a committee to review the  company's actions prior to the voluntary withdrawal of its  painkiller Vioxx.
237814
Merck (MRK) officials on Wednesday called a press conference to reiterate that they did not believe until last month that Vioxx raised users&#39; risk of heart attacks or strokes.
22206
Internal e-mails and other documents from Merck &amp; Co. show the company fought for years to keep safety concerns from undermining the drug&#39;s commercial prospects, the Wall Street Journal reported on Monday.
733605
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc  and Schering-Plough's  cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
159888
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way it monitors safety risks associated with medicines already  on the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
494116
A leading U.S. Senate Republican  this week demanded internal documents from Merck & Co. Inc.  MRK.N that could answer questions about the company's  interaction with U.S. regulators over its arthritis drug Vioxx.
732137
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc and Schering-Plough's cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
416045
Merck & Co Inc. is evaluating why  its withdrawn painkiller Vioxx raises the chance of heart  attack and stroke, but it has not found a mechanism of action,  a company official said on Monday.
292638
The directors of Merck, the giant drug maker, have opened an independent investigation into whether the company acted properly regarding Vioxx, the arthritis treatment that it withdrew from the market in September.
485027
Drug maker Merck &amp; Co. reported Tuesday that its board appointed a special committee to review the company&#39;s actions before withdrawing blockbuster arthritis drug Vioxx from the market Sept.
368795
The U.S. Food and Drug Administration on Friday asked an outside group to review the way the agency monitors safety risks of medicines after they hit the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.
313143
Description: A scientist singles out five drugs as unsafe while testifying before a Senate committee on the Food and Drug Administration&#39;s oversight of Vioxx.
459082
Description: Drug maker Merck knew about the health risks of taking the pain medication Vioxx long before it pulled the drug from the market, The Wall Street Journal reports.
226044
U.S. health officials said on Friday  they would review whether to take regulatory action over Merck  & Co Inc  and Schering-Plough's  cholesterol  medicine Vytorin following the drug's failure to work better  than a generic drug in a study of plaque build-up in neck  arteries.